Amendment No. 2 to the Exclusive License Agreement, dated April 17, 2013, by and among the Registrant, The Regents of the University of California, and the University of Vienna
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder identified by the mark [***].
Amendment No. 2 to Exclusive License Agreement for Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription
This Amendment No. 2 is made to the Exclusive License Agreement for Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription, dated April 16, 2013, as amended by an Amendment Agreement, dated April 17, 2013 (collectively, the License Agreement), by and among The Regents of the University of California, the University of Vienna, and Caribou Biosciences, Inc., and is effective March 14, 2019 (the Amendment Effective Date). Caribou Biosciences, Inc. is referred to as LICENSEE and The Regents of the University of California (REGENTS) and the University of Vienna are collectively referred to as LICENSORS. Capitalized terms not defined herein shall have the meaning set forth in the License Agreement.
WHEREAS, LICENSEE and LICENSORS wish to amend the License Agreement, as set forth herein.
NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valid consideration, the amount and sufficiency of which are hereby acknowledged, LICENSEE and LICENSORS agree as follows:
All other terms of the License Agreement, as clarified in the Memorandum of Understanding, dated as of the same date as the Amendment Effective Date, shall remain in full force and effect.
This Amendment No. 2 may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together will be deemed to be one and the same instrument. PDF or facsimile execution and delivery of this Amendment No. 2 by a party will constitute a legal, valid, and binding execution and delivery of this Amendment No. 2 by such party.
IN WITNESS WHEREOF, the parties hereto have executed this Amendment No. 2 as of the Amendment Effective Date by their duly authorized officers or representatives.
|THE REGENTS OF THE UNIVERSITY OF CALIFORNIA||THE UNIVERSITY OF VIENNA|
|CARIBOU BIOSCIENCES, INC.|
|Name:||Rachel E. Haurwitz, Ph.D.|
|Title:||President & CEO|